Related Experiment Video
Updated: Oct 18, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
Characterization of glycosylphosphatidylinositol-linked molecule CD55/decay-accelerating factor as the receptor for
F Hensel1, R Hermann, C Schubert
1Institut für Pathologie, Würzburg, Germany.
Abstract:
The human monoclonal antibody SC-1 induces apoptosis of stomach carcinoma cells and is currently used in a clinical Phase II trial. The antibody binds to a target molecule that is preferentially expressed on diffuse- and intestinal-type stomach cancer cells and shows a very restricted expression on other normal and malignant tissues. In this paper, we show that the SC-1 receptor is a stomach carcinoma-associated isoform of CD55 [membrane-bound decay-accelerating factor (DAF)-B] with a relative molecular mass of approximately 82 kDa. The antigenic site of SC-1 is an N-linked carbohydrate residue. Cross-linking of the DAF receptor increases apoptotic activity. SC-1 binding induces tyrosine phosphorylation of three proteins of approximately 60, 75, and 110 kDa, whereas a serine residue of an approximately 35-kDa protein is dephosphorylated. Expression of caspase-3 (CPP32) and caspase-8 (FLICE) is elevated, and activation of these caspases occurs. These data show that a tumor-specific variant form DAF is involved in apoptosis and can be used for adjuvant therapeutical purposes on gastric carcinoma.
Insights
The human monoclonal antibody SC-1 targets a unique stomach cancer cell receptor, a variant of CD55 (decay-accelerating factor). This antibody triggers cancer cell death, offering potential for gastric carcinoma treatment.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Human monoclonal antibody SC-1 induces apoptosis in stomach carcinoma cells.
- SC-1 targets a molecule preferentially expressed on diffuse- and intestinal-type stomach cancers with restricted normal tissue expression.
Purpose of the Study:
- Identify the SC-1 receptor.
- Elucidate the mechanism of SC-1-induced apoptosis in gastric carcinoma.
Main Methods:
- Immunoprecipitation and Western blotting to identify the SC-1 receptor.
- Analysis of protein phosphorylation and caspase activation.
- Assessment of SC-1 binding and receptor cross-linking effects.
Main Results:
- The SC-1 receptor is identified as a stomach carcinoma-associated isoform of CD55 (DAF-B), approximately 82 kDa.
- SC-1's antigenic site is an N-linked carbohydrate residue.
- SC-1 binding induces tyrosine phosphorylation of specific proteins and dephosphorylation of another, alongside elevated expression and activation of caspases-3 and -8.
Conclusions:
- A tumor-specific variant of DAF is involved in gastric carcinoma apoptosis.
- SC-1 shows potential as an adjuvant therapeutic agent for gastric carcinoma.
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Extrinsic Apoptotic Pathway

